Placental angiogenic factors are associated with maternal thyroid function and modify HCG-mediated FT4 stimulation

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 10, 2015, Pages E1328-E1334

  Korevaar, Tim I M ^a,b   Steegers, Eric A P ^c   De Rijke, Yolanda B ^b,c   Visser, W Edward ^b   Jaddoe, Vincent W V ^a,b,d   Visser, Theo J ^b   Medici, Marco ^b   Peeters, Robin P ^b  

^a Generation R Study Group   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Rotterdam Thyroid Center ^*  (France)

^d SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; PLACENTAL GROWTH FACTOR; THYROTROPIN; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; LIOTHYRONINE; PLACENTA PROTEIN; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; FREE THYROXINE INDEX; GESTATIONAL AGE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPOTHYROIDISM; HYPOTHYROXINEMIA; MATERNAL PLASMA; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; THYROID DISEASE; THYROID FUNCTION; BLOOD; PHYSIOLOGY; THYROID GLAND; YOUNG ADULT;

ADOLESCENT; ADULT; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; PREGNANCY; PREGNANCY PROTEINS; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84943767050     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-2553     Document Type: Article

References (29)

1. Chan S, Boelaert K. Optimal management of hypothyroidism, hypothyroxinaemia and euthyroid TPO antibody positivity preconception and in pregnancy. Clin Endocrinol. 2015;82:313-326.
2. Medici M, Korevaar TI, Schalekamp-Timmermans S, et al. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: The generation R study. J Clin Endocrinol Metab. 2014;99:E2591-E2598.
3. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008;21:9-23.
4. Coolman M, Timmermans S, de Groot CJ, et al. Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes. Obstet Gynecol. 2012;119:1190-1200.
5. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991; 88:9267-9271.
6. Korevaar TI, Steegers EA, Schalekamp-Timmermans S, et al. Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: The Generation R Study. J Clin Endocrinol Metab. 2014;99(9):E1627-E1634.
7. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen-A review. Placenta. 2000;21 Suppl A:S16-S24.
8. Ali KZM, Burton GJ, Al-Binali AM, et al. Concentration of free vascular endothelial growth factor and its soluble receptor, sFlt-1 in the maternal and fetal circulations of normal term pregnancies at high and low altitudes. J Matern Fetal Neonatal Med. 2012;25: 2066-2070.
9. Clark DE, Smith SK, He Y, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod. 1998;59:1540-1548.
10. Yang Y, Zhang Y, Cao Z, Ji H, et al. Anti-VEGF-and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues. Proc Natl Acad Sci U S A. 2013;110:12018-12023.
11. Kamba T, Tam BY, Hashizume H, et al. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.AmJ Physiol Heart Circ Physiol. 2006;290:H560-H576.
12. Levine RJ, Vatten LJ, Horowitz GL, et al. Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: Nested case-control and population based study. BMJ. 2009;339: b4336.
13. Kang MC, Park SJ, Kim HJ, et al. Gestational loss and growth restriction by angiogenic defects in placental growth factor transgenic mice. Arterioscler Thromb Vasc Biol. 2014;34:2276-2282.
14. Cao Y. Positive and negative modulation of angiogenesis by VEGFR1 ligands. Sci Signal. 2009;2:re1.
15. Eriksson A, Cao R, Pawliuk R, et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell. 2002;1:99-108.
16. Medici M, de Rijke YB, Peeters RP, et al. Maternal early pregnancy and newborn thyroid hormone parameters: The Generation R study. J Clin Endocrinol Metab. 2012;97:646-652.
17. Jaddoe VW, van Duijn CM, Franco OH, et al. The Generation R Study: Design and cohort update 2012. Eur J Epidemiol. 2012;27: 739-756.
18. Verburg BO, Steegers EA, De Ridder M, et al. New charts for ultrasound dating of pregnancy and assessment of fetal growth: Longitudinal data from a population-based cohort study. Ultrasound Obstet Gynecol. 2008;31:388-396.
19. Korevaar TI, Medici M, de Rijke YB, et al. Ethnic differences in maternal thyroid parameters during pregnancy: The Generation R study. J Clin Endocrinol Metab. 2013;98:3678-3686.
20. Medici M, Ghassabian A, Visser W, et al. Women with high early pregnancy urinary iodine levels have an increased risk of hyperthyroid newborns: The population-based GenerationRStudy. Clin Endocrinol (Oxf). 2014;80:598-606.
21. Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, van der Wal MF, Bonsel GJ. Ethnic differences in TSH but not in free T4 concentrations or TPO antibodies during pregnancy. Clin Endocrinol. 2007;66:765-770.
22. Männistö T, Surcel HM, Ruokonen A, et al. Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population. Thyroid. 2011;21:291-298.
23. Shi X, Han C, Li C, et al. Optimal and safe upper limits of iodine intake for early pregnancy in iodine-sufficient regions: A cross-sectional study of 7,190 pregnant women in China. J Clin Endocrinol Metab. 2015;100(4):1630-1638.
24. Yu X, Shan Z, Li C, et al. Iron Deficiency, an Independent Risk Factor for Isolated Hypothyroxinemia in Pregnant and Non-pregnant Women of Childbearing age in China. J Clin Endocrinol Metab. 2015;100(4):1594-1601.
25. Korevaar TI, Steegers EA, Schalekamp-Timmermans S, et al. Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: The generation R study. J Clin Endocrinol Metab. 2014;99:E1627-1634.
26. Zygmunt M, Herr F, Keller-Schoenwetter S, et al. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab. 2002;87:5290-5296.
27. Berndt S, Perrier d'Hauterive S, Blacher S, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. FASEB J. 2006;20:2630-2632.
28. Depoix C, Tee MK, Taylor RN. Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway. Reprod Sci. 2011;18:219-228.
29. Ascoli M, Fanelli F, Segaloff DL. The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev. 2002;23:141-174.